4164F Adjv hrmnl thxpy rxd
Also known as: adjuvant hormonal therapy prostate measure, androgen deprivation therapy measure, hormone therapy prostate cancer
Performance measure code indicating that adjuvant hormonal therapy was prescribed or recommended for prostate cancer.
In Plain Language
prostate cancer hormone treatment; testosterone-blocking medication; hormone therapy for prostate cancer
Clinical Context
Quality measure tracking prescription of adjuvant androgen deprivation therapy in appropriate prostate cancer patients based on stage and risk.
RVU Information
CPT 4164F does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Documentation should include the clinical indication, service details, and any applicable performance metrics. Coverage may vary by payer — verify acceptance before billing.
Specialties
Frequently Asked Questions
What is CPT code 4164F?
CPT 4164F (Adjv hrmnl thxpy rxd) is a Other code. Performance measure code indicating that adjuvant hormonal therapy was prescribed or recommended for prostate cancer.
Who uses CPT code 4164F?
CPT 4164F is used by Urology, Oncology, Surgical Oncology. Quality measure tracking prescription of adjuvant androgen deprivation therapy in appropriate prostate cancer patients based on stage and risk.
When is CPT 4164F used?
Quality measure tracking prescription of adjuvant androgen deprivation therapy in appropriate prostate cancer patients based on stage and risk.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.